Related Experiment Videos

Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study

J-C Luo1, H-B Leu, M-C Hou

  • 1Department of Medicine, National Yang-Ming University, School of Medicine, Taipei City, Taiwan. jcluo@vghtpe.gov.tw

Alimentary Pharmacology & Therapeutics
|July 24, 2012
PubMed

Insights

Cirrhotic patients face a significantly higher risk of peptic ulcer bleeding (PUB) compared to the general population. Key risk factors in this group include age, male gender, diabetes, and certain medications.

Area of Science:

  • Gastroenterology and Hepatology
  • Clinical Epidemiology

Background:

  • Peptic ulcer bleeding (PUB) risk in patients with cirrhosis is not well-established through large population studies.
  • Comparing PUB incidence between cirrhotic and non-cirrhotic individuals is crucial for risk assessment.

Purpose of the Study:

  • To determine if cirrhotic patients have an elevated risk of PUB compared to the general population.
  • To identify specific risk factors for PUB within the cirrhotic patient cohort.

Main Methods:

  • A nationwide population-based study in Taiwan utilizing the National Health Insurance Research Database.
  • Propensity score matching was employed to compare 4013 cirrhotic patients with chronic hepatitis patients and normal controls.
  • Cox proportional hazard regressions analyzed PUB risk factors in all patients and specifically in cirrhotic individuals.

Main Results:

  • Cirrhotic patients exhibited significantly higher PUB incidence rates than both chronic hepatitis patients and controls (P < 0.001).
  • Cirrhosis was an independent predictor of increased PUB risk (Hazard Ratio: 4.22; 95% CI 3.37-5.29).
  • Identified risk factors for PUB in cirrhotic patients included older age, male gender, diabetes, chronic renal disease, variceal bleeding history, and NSAID use.

Conclusions:

  • Cirrhotic patients demonstrate a substantially elevated risk of peptic ulcer bleeding.
  • This increased risk persists even after adjusting for confounding factors such as age, gender, comorbidities, and ulcerogenic medications.
Abstract

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...